MAIORCA, Rosario
 Distribuzione geografica
Continente #
NA - Nord America 6.300
EU - Europa 3.781
AS - Asia 1.963
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 12
AF - Africa 8
SA - Sud America 6
Totale 12.083
Nazione #
US - Stati Uniti d'America 6.266
UA - Ucraina 1.899
CN - Cina 1.398
DE - Germania 593
HK - Hong Kong 415
FI - Finlandia 353
IT - Italia 346
IE - Irlanda 230
GB - Regno Unito 129
FR - Francia 110
IN - India 69
SE - Svezia 50
SG - Singapore 33
CA - Canada 30
IR - Iran 19
TR - Turchia 19
BE - Belgio 17
AU - Australia 13
EU - Europa 12
NL - Olanda 10
PL - Polonia 5
RO - Romania 5
RU - Federazione Russa 5
GR - Grecia 4
LV - Lettonia 4
MX - Messico 4
PE - Perù 4
AT - Austria 3
HR - Croazia 3
AM - Armenia 2
BG - Bulgaria 2
CH - Svizzera 2
ES - Italia 2
KR - Corea 2
LU - Lussemburgo 2
MA - Marocco 2
MU - Mauritius 2
SA - Arabia Saudita 2
AR - Argentina 1
BA - Bosnia-Erzegovina 1
BR - Brasile 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
GH - Ghana 1
HU - Ungheria 1
ID - Indonesia 1
IL - Israele 1
JP - Giappone 1
KZ - Kazakistan 1
LT - Lituania 1
NG - Nigeria 1
PT - Portogallo 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
ZA - Sudafrica 1
Totale 12.083
Città #
Jacksonville 1.166
Woodbridge 816
Fairfield 654
Princeton 466
Houston 426
Hong Kong 412
Ann Arbor 402
Nanjing 398
Cambridge 346
Chandler 336
Ashburn 298
Wilmington 282
Dublin 229
Seattle 224
Nanchang 153
Beijing 143
Helsinki 119
Des Moines 110
Shenyang 105
Hebei 83
New York 83
Tianjin 69
Changsha 67
Milan 67
Jiaxing 66
Dearborn 64
Jinan 56
San Diego 44
Hangzhou 42
Verona 41
Kunming 36
Lanzhou 28
San Mateo 28
Ningbo 27
Toronto 26
Norwalk 21
Monmouth Junction 18
Shanghai 18
Ardabil 16
Kocaeli 15
Leawood 15
Zhengzhou 15
San Francisco 14
Taizhou 14
Brussels 13
Rome 12
Haikou 11
Augusta 9
Guangzhou 9
Taiyuan 9
Washington 9
Changchun 7
Catania 6
Menlo Park 6
Orange 6
Canberra 5
Edinburgh 5
Hefei 5
Melbourne 5
Athens 4
Carbonia 4
Cosenza 4
Lancaster 4
Palermo 4
Venezia 4
Bangalore 3
Fuzhou 3
Hanover 3
Lima 3
London 3
Redwood City 3
Torino 3
Vienna 3
Azzano San Paolo 2
Baotou 2
Bari 2
Bologna 2
Brescia 2
Caserta 2
Central 2
Chiswick 2
Cremona 2
Icheon-si 2
Illingen 2
Inwood 2
Jesi 2
Kilburn 2
Lanuvio 2
Livorno 2
Los Angeles 2
Madrid 2
Mountain View 2
Napoli 2
Paris 2
Pune 2
Rabat 2
Radomsko 2
Redmond 2
Riga 2
San Martino Buon Albergo 2
Totale 8.277
Nome #
A prospective randomized trial on azathioprine addition to cyclosporine versus cyclosporine monotherapy at steroid withdrawal, 6 months after renal transplantation. 117
Acute visual disorders in patients on regular dialysis given desferrioxamine as a test 111
Assessment of calcemic status in dialyzed uraemic patients. 109
Effects of changes in intravascular volume on atrial size and plasma levels of immunoreactive atrial natriuretic peptide in uremic man 108
A controlled trial of two bicarbonate-containing dialysis fluids for CAPD--final report. 108
A large TSC2 and PKD1 gene deletion is associated with renal and extrarenal signs of autosomal dominant polycystic kidney disease 107
Which vascular access for chronic hemodialysis in uremic elderly patients? 101
Predictive value of dialysis adequacy and nutritional indices for mortality and morbidity in CAPD and HD patients: a longitudinal study. 101
Viral hepatitis in HBsAg-positive renal transplant patients treated with cyclosporin and steroids. 100
Liver disease in renal transplant patients treated with azathioprine or ciclosporin. 99
Inter-dialytic variations in blood volume and total body water in uraemic patients treated by dialysis. 98
A six year comparison of patient and technique survivals in CAPD and HD 97
La sindrome oro-facio-digitale tipo 1: una causa infrequente di malattia cistica renale a carattere ereditario. 97
A randomized controlled trial of a bicarbonate - and a bicarbonate/lactate - containing dialysis solution in CAPD 95
Adequacy of dialysis reduces the doses of recombinant erythropoietin independently from the use of biocompatible membranes in haemodialysis patients 94
Antiphospholipid syndrome and glomerular thrombosis in the absence of overt lupus nephritis 94
Von Hippel-Lindau syndrome presenting as pancreatic cysts 94
Correction of metabolic acidosis increases serum albumin concentrations and decreases kinetically evaluated protein intake in haemodialysis patients: a prospective study. 93
Viral infection in kidney-transplanted patients. 92
Interrelationships between blood pressure, blood gases and plasma acetate concentrations during conventional hemodialysis. 90
Plasma catecholamine response to postural stimulation in normotensive and dialysis hypotension-prone uremic patients. 89
Two different types of renal involvement in tuberous sclerosis complex. 88
Oral-facial-digital syndrome type I: an unusual cause of hereditary cystic kidney disease 88
Predictors of renal and patient outcomes in atheroembolic renal disease: a prospective study 88
Sarcoma di Kaposi (SK) in corso di trapianto renale. Esperienza clinica in 7 casi. 88
Iperplasia gengivale indotta da ciclosporina: aspetti clinici e istologici. 87
Oral-facial-digital syndrome type 1 coexisting with polycystic kidney disease. 86
Cholesterol atheromatous embolism: an increasingly recognized cause of acute renal failure. 85
Evidence for an independent role of metabolic acidosis on nutritional status in haemodialysis patients. 83
Kidney transplantation in Alport's syndrome. 83
Medullary cystic kidney disease: past and present. 83
Phosphate may promote CKD progression and attenuate renoprotective effect of ACE inhibition. 83
PD or not PD? That is the question. 82
Nephronophthisis-medullary cystic kidney disease complex: a report on 24 patients from 5 families with Italian ancestry. 82
Cyclosporin and renal injury. 82
Outcome of peritoneal dialysis: comparative studies. 81
Chronic Ambulatory Peritoneal Dialysis 80
Renal transplantation and peritoneal dialysis 80
Management of hypertension in chronic renal failure. 80
Predialysis versus postdialysis hematocrit evaluation during erythropoietin therapy. 79
Prevention of peritonitis during CAPD: special precautions and use of connection systems. 78
Reliability of clinical parameters for the selection of elderly cadaveric donors. 77
Clinical and morphological features of kidney involvement in primary Sjogren's syndrome. 77
Kidney transplantation in peritoneal dialysis patients. 76
Trough cyclosporine concentration variability. 76
Ciclosporin in renal transplantation: identification of two populations with different drug metabolism. 76
Integration of peritoneal dialysis and transplantation programs. 75
Direct effect of the correction of acidosis on plasma parathyroid hormone concentrations, calcium and phosphate in hemodialysis patients: a prospective study. 72
Prospective controlled trial of a Y-Connector and disinfectant to prevent peritonitis in CAPD 71
Behavior of plasma catecholamines in relation to pressure changes induced with hemodialysis or ultrafiltration 69
Approccio fisiopatologico alla terapia della ipertensione arteriosa nella nefropatia diabetica. 67
32 cases of familial primary glomerulonephritis: HLA do not play a role in the genetic mechanism of the disease. 67
Steroid withdrawal six months after renal transplantation: comparison between azathioprine and cyclosporine versus cyclosporyne on monotherapy. A randomized monocenter trial. 67
Clinical evaluation of a peritoneal dialysis solution with 33 mmol/L bicarbonate. 65
Which treatment for which patients in the future? Possible modifications in CAPD 65
CAPD viability: a long-term comparison with hemodialysis 65
'Y' connector system for prevention of peritonitis in CAPD: a controlled study. 64
Access site-related infection in dialysis: the AStRID project: a multicenter prospective Italian study. 64
Acquired haemolytic anemia (AHA) following ABO minor incompatibility: a rare example of graft versus host disease (GVHD) after renal transplantation (TX). 64
Are cyclosporine (Cs) deposits (DPS) in renal allografts of clinical significance? 63
Antibodies to HTLV III: epidemiological study in hemodialyzed, CAPD and transplanted patients. 61
Deposits of Cyclosporin in the renal allograft. 61
Is cyclosporine administration in twice daily dose in renal transplant advantageous? 60
Embolizzazione da cristalli di colesterolo (ECC): una causa crescente di insufficienza renale acuta. 60
Evidence for the existence of a positive feedback of the degree of expansion of the circulating volume, atrial distension and atrial natriuretic peptide in dialyzed uremic patients 58
The role of nephrogenous cGMP (NcGMP) as a mediator of PTH activity on renal tubules. A study of normal and nephropathic subjects with different reductions in glomerular filtrate 58
32 casi di glomerulonefrite primitiva a carattere familiare: esiste un ruolo dell'HLA? 58
Anemia emolitica autoimmune acquisita (AEAA) da incompatibilità minore ABO: un raro esempio di graft versus host disease (GVHD) in corso di trapianto di rene (TX). 58
"Nocardiosi sistemica in corso di trapianto renale: quale strategia terapeutica ?". 58
ABO-minor-incompatible kidney transplantation: not only O grafts can produce immune hemolysis. 56
Hospitalization: CAPD versus hemodialysis and transplant. 55
Plasma porphyrins in patients treated with hemodialysis 55
Utilità della scintigrafia con 99m Tc solfocolloidale nella diagnosi di rigetto nel rene trapiantato. 55
Trombosi capillare glomerulare in assenza di immuno-depositi: inusuale coinvolgimento renale in paziente con LES ed anticorpi anticardiolipina. 54
Long-term peritoneal dialysis outcome in a single center. 53
La plasmaferesi nel trattamento del rigetto acuto di allotrapianto di rene. Risultati di uno studio aperto e dati preliminari su uno studio controllato. 53
Cyclosporine-induced gingival hyperplasia: clinical and pathological findings. ? 53
Kaposi (SK) complicating renal transplantation (TX): a report on 7 cases from a sigle centre. 52
Anticorpi anti HTLV III: studio epidemiologico in pazienti in dialisi e trapiantati renali. 52
Glomerulonefrite IgA a carattere familiare; studio immunologico ed immunogenetico. 51
Sindrome di Alport associata a leiomiomatosi diffusa: una sindrome da geni contigui. 51
Cholesterol atheromatous embolism (CAE): an increasingly recognized cause of acute renal failure (ARF). 51
Anticorpi anti- HCV e HCV- RNA nel siero, nei linfociti e nel criocrito di pazienti con CME e coinvolgimento renale. 51
Experiences with the Y-system 50
Thirty years of progress in peritoneal dialysis. 50
La glomerulonefrite da catene leggere: una rara manifestazione delle gammopatie monoclonali. Descrizione di due casi associati a gammopatia monoclonale benigna. 50
Assenza di effetti aritmogeni di alte dosi di steroide E.V. in pazienti con sindrome nefrosica. 50
Type II Cryoglobulinemia with renal disease: HCV infection and follow up. 50
"Fluconazole-resistant cryptococcal cellulitis in a kidney transplant patient". 50
Ricorrenza familiare di glomerulonefrite primitiva: esperienza di un singolo centro. 50
Light chain nephropathy or light chain disease? 50
Sindrome iponatriemica da inappropriata secrezione di ADH (SIADH). Inusuale coinvolgimento cerebrale in paziente con LES e anticorpi anticardiolipina. 50
Cyclosporin induced chronic nephrotoxicity : hystological evaluation 6 and 18 months after renal transplantation. 50
Techniques, complications, and indications of peritoneal dialysis. 49
Inappropriate ADH secretion: an unusual manifestation of antiphospholipid syndrome? 49
Iperplasia gengivale indotta da ciclosporina (Cs): considerazioni cliniche e morfologiche. 49
E' evitabile la nefrotossicità acuta da Ciclosporina? 49
Is cyclosporine-induced chronic nephrotoxicity inevitable? 48
Effetto renoprotettivo delle statine nei pazienti con malattia renale ateroembolica (MRA). 48
IRA da embolizzazione renale da cristalli di colesterolo: ruolo scatenante dell'aortografia e della terapia trombolitica. 48
Totale 7.194
Categoria #
all - tutte 54.113
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.113


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019375 0 0 0 0 0 0 0 0 0 0 188 187
2019/20203.257 725 54 58 387 96 374 234 373 142 471 76 267
2020/20212.549 23 297 29 301 36 398 47 407 429 201 347 34
2021/20221.421 71 351 5 39 15 50 53 91 73 198 128 347
2022/20231.126 241 6 24 107 73 351 0 109 129 3 47 36
2023/2024845 48 12 68 86 19 111 42 32 421 5 1 0
Totale 12.329